2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Metastatic Uveal Melanoma
Metastatic Uveal Melanoma poses a significant challenge in cancer research due to its aggressive nature and limited treatment options. This rare form of eye cancer often spreads to the liver, where it becomes especially difficult to treat. Researchers are exploring various approaches, including targeted therapies and immunotherapies, to improve outcomes for patients. Recent advancements in understanding the molecular mechanisms driving uveal melanoma metastasis offer hope for developing more effective treatments. Additionally, ongoing clinical trials are investigating novel treatment combinations and precision medicine strategies tailored to individual patients' genetic profiles. Despite the challenges, the dedication of researchers and clinicians continues to drive progress towards finding better therapies and ultimately improving survival rates for patients with metastatic uveal melanoma.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China